Xilio Development Correlations

XLO Stock

USD 0.58 0.02 3.30%

The current 90-days correlation between Xilio Development and PDS Biotechnology Corp is 0.2 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xilio Development moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xilio Development moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Xilio Development Correlation With Market

Pay attention - limited upside

The correlation between Xilio Development and DJI is -0.77 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xilio Development and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Xilio Stock

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.

Moving together with Xilio Stock

0.7	DWTX	Dogwood Therapeutics	Pair Corr
0.8	EDIT	Editas Medicine Earnings Call This Week	Pair Corr
0.61	EVGN	Evogene	Pair Corr
0.89	ABP	Abpro Holdings	Pair Corr
0.84	QSI	QuantumSi	Pair Corr
0.83	GNLX	Genelux Common	Pair Corr
0.8	IMRN	Immuron Ltd ADR	Pair Corr
0.81	KURA	Kura Oncology	Pair Corr
0.79	LYRA	Lyra Therapeutics	Pair Corr
0.9	MBIO	Mustang Bio	Pair Corr
0.65	MREO	Mereo BioPharma Group	Pair Corr
0.67	PROK	ProKidney Corp	Pair Corr
0.76	PRQR	ProQR Therapeutics Earnings Call This Week	Pair Corr
0.85	ACXP	Acurx Pharmaceuticals LLC	Pair Corr

Moving against Xilio Stock

0.72	DSGN	Design Therapeutics	Pair Corr
0.7	IMMP	Immutep Ltd ADR	Pair Corr
0.69	ENGN	enGene Holdings Common	Pair Corr
0.41	KYTX	Kyverna Therapeutics	Pair Corr
0.33	63E	ONWARD MEDICAL BV	Pair Corr
0.81	SLDB	Solid Biosciences LLC	Pair Corr
0.73	ANNX	Annexon Downward Rally	Pair Corr
0.72	AVE	Avecho Biotechnology	Pair Corr
0.6	AVCR	Avricore Health	Pair Corr
0.59	MRKR	Marker Therapeutics	Pair Corr
0.47	BOLT	Bolt Biotherapeutics	Pair Corr
0.9	SMFG	Sumitomo Mitsui Financial	Pair Corr
0.89	SMFNF	Sumitomo Mitsui Financial Normal Trading	Pair Corr
0.88	MFG	Mizuho Financial	Pair Corr
0.85	MBFJF	Mitsubishi UFJ Financial Normal Trading	Pair Corr

Related Correlations Analysis

	PDSB	ATNM	TPST	OKUR	LVTX	KZR	FGEN	SKYE	TVRD	ALGS
PDSB		0.36	0.13	0.73	-0.2	0.18	-0.1	0.25	0.74	0.33	PDSB
ATNM	0.36		-0.02	0.47	-0.6	0.63	0.01	0.15	0.16	0.77	ATNM
TPST	0.13	-0.02		0.32	-0.29	-0.21	0.53	0.72	-0.02	-0.42	TPST
OKUR	0.73	0.47	0.32		-0.46	0.25	0.22	0.44	0.62	0.38	OKUR
LVTX	-0.2	-0.6	-0.29	-0.46		-0.34	-0.34	-0.42	-0.2	-0.41	LVTX
KZR	0.18	0.63	-0.21	0.25	-0.34		-0.13	-0.18	0.06	0.63	KZR
FGEN	-0.1	0.01	0.53	0.22	-0.34	-0.13		0.75	-0.11	0.03	FGEN
SKYE	0.25	0.15	0.72	0.44	-0.42	-0.18	0.75		0.08	-0.04	SKYE
TVRD	0.74	0.16	-0.02	0.62	-0.2	0.06	-0.11	0.08		0.22	TVRD
ALGS	0.33	0.77	-0.42	0.38	-0.41	0.63	0.03	-0.04	0.22		ALGS
	PDSB	ATNM	TPST	OKUR	LVTX	KZR	FGEN	SKYE	TVRD	ALGS

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ALGS	+ 0.77	ATNM
SKYE	+ 0.75	FGEN
TVRD	+ 0.74	PDSB
OKUR	+ 0.73	PDSB
SKYE	+ 0.72	TPST
KZR	+ 0.63	ATNM

High negative correlations

LVTX	- 0.6	ATNM
LVTX	- 0.46	OKUR
SKYE	- 0.42	LVTX
ALGS	- 0.42	TPST
ALGS	- 0.41	LVTX
FGEN	- 0.34	LVTX

Risk-Adjusted Indicators

There is a big difference between Xilio Stock performing well and Xilio Development Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xilio Development's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PDSB	4.13	(0.46)	0.00	(0.15)	0.00	0.00	8.08	(8.41)	27.78
ATNM	2.99	(0.17)	0.00	(0.22)	0.00	0.00	5.84	(5.43)	20.75
TPST	4.76	(1.73)	0.00	(2.02)	0.00	0.00	7.62	(9.56)	52.01
OKUR	3.70	(0.28)	0.00	(0.18)	0.00	0.00	7.76	(6.92)	25.44
LVTX	1.33	0.17	0.07	0.62	1.19	(2.29)	4.70	(2.63)	14.75
KZR	0.75	0.04	(0.01)	0.25	1.00	(0.87)	1.60	(1.27)	7.79
FGEN	2.66	(0.08)	0.00	0.12	0.00	0.00	4.33	(5.28)	28.75
SKYE	4.79	(1.03)	0.00	(1.00)	0.00	0.00	10.19	(8.05)	25.49
TVRD	2.63	(0.15)	0.00	(0.06)	0.00	0.00	5.59	(5.80)	17.90
ALGS	4.70	0.10	0.01	0.23	5.28	(5.16)	11.50	(8.20)	28.43

Xilio Development Corporate Management

Martin MD	Pres RD	Profile
Scott Coleman	Chief Officer	Profile
Uli Bialucha	Chief Officer	Profile
Ruth Moulin	Senior Affairs	Profile
Julissa Viana	Vice Communications	Profile
Stacey Davis	Chief Officer	Profile
Christopher Frankenfield	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC